Home Infusion Therapy Market Size To Reach USD 38.41 Billion By 2026 – Reports and Data

Ageing demographics, rapid technological developments, increasing adoption of home infusion therapies, favourable government policies and regulations are are key factors contributing to high CAGR of Home infusion therapy during forecast period.

According to current analysis of Reports and Data, the global Home Infusion Therapy Market was valued at USD 22.03 billion in 2018 and is expected to reach USD 38.41 billion by the year 2026, at a CAGR of 7.2%. Infusion therapy involves the administration of drugs intravenously. It is prescribed when a patient’s condition is much severe and cannot be treated effectively by oral medications. Receiving this therapy in homecare settings rather than hospitals is referred to as home infusion therapy. Home infusion therapies are very cost-effective, and technological advancements have facilitated safe and effective administration of infusion therapies at home. The advantage infusion offers is that it helps deliver a precise dose of the drug quickly and efficiently, and in a well-controlled manner throughout the body. It is also used for irritating solutions; those can cause pain and even damage tissues if administered by subcutaneous or intramuscular injection.

Moving care into the home is a very important step of change in healthcare. The approach is patient-centric. Home infusion therapy let patients reduce or even totally avoid outpatient hospital visits, and allows them to resume normal routines and work behaviors while still treating their illness. Home infusion therapy works closely with the patient to ensure that such services are appropriate and in the interest of the best patient care. Moreover, the outcome of home infusion therapy is reliable.  Favorable government policies and regulations, increasing geriatric population, rapid technological developments, and increasing adoption of home infusion therapies, are some of the key factors propelling market growth in the industry. High prevalence of chronic diseases such as HIV, cancer, diabetes is further expected to fuel market growth. Home infusion drugs are often not readily available through standard pharmacies and comparatively higher in cost. Most are obtained through hospital pharmacies, licensed home infusion agencies, or mail-order discount drug supply companies that can express deliver the drugs directly to the patient’s home. However, increasing risk with patient’s safety and occurrence of mistakes while using infusion devices and issues related to reimbursement policies for home infusion therapy are the major hindrance for market growth during the forecast period.

Get a sample of the report @ https://www.reportsanddata.com/sample-enquiry-form/2250  

Further key findings from the report suggest

• Home Infusion Therapy is growing at a CAGR of 3% in Asia Pacific followed by North America and Europe, with 7.2 % and 6.9% CAGR, respectively. High incidence of chronic diseases and availability of cost-effective home infusion therapies in developing and developed economies are expected to accelerate the market growth for home infusion therapy during forecast period across all regions
• As of 2018, Anti-infective application segment is expected to dominate Home infusion therapy which holds the market share of 33.9% of the global market. North America region is the chief revenue generating source for this product segment, followed by Europe and Asia-Pacific regions
• Chemotherapy is expected to be the fastest growing market segment during forecast period 2019-2026 with a CAGR of 7.7%. It is also the second largest segment in terms of revenue generation after anti-infective segment. For instance, according to the data of cancer organization, by January 1 2030, it is estimated that the population of cancer survivors will increase to more than 22.1 million due to the growth and aging of the population alone
• Infusion pumps segment led the global infusion therapy market with a market share of 34.7% in 2018 and is forecasted to continue its dominance during the forecast period. Extensive application in delivering fluids containing nutrients and medications in controlled dosages is anticipated to fuel market growth
• Needleless connectors segment is anticipated to witness lucrative growth with a CAGR of 7.9% registering fastest growth during the forecast period.
• Key players in the home infusion therapy industry are taking initiatives to educate and promote home infusion therapy among the patients by providing educational tools and apps that can be utilized for infusion therapies. For instance, in October 2018, Baxter International Inc. in collaboration with American Society for Parenteral and Enteral Nutrition (ASPEN) launched SmartPN tool to help reduce clinical malnutrition.
• Asia Pacific is expected to account for the 21.1% of the global Home Infusion Therapy. Developing nations such China, and India are likely to witness high growth
• North America region accounts for the largest market share of 37.6% followed by Europe
• Key participants include Baxter, B. Braun Melsungen AG, ICU Medical Inc., Fresenius Kabi AG, Terumo Corporation, JMS Co. Ltd., CareFusion Corporation, Smiths Medical and Caesarea Medical Electronics.

Request a discount on the report @ https://www.reportsanddata.com/discount-enquiry-form/2250

For the purpose of this report, Reports and Data has segmented the Home Infusion Therapy on the basis of product, application, and region:

Product (Revenue, USD Million; 2016–2026)

• Infusion pumps
• Intravenous sets
• IV Cannulas
• Needleless connectors

Application (Revenue, USD Million; 2016–2026)

• Anti- infective
• Endocrinology
• Hydration therapy
• Chemotherapy
• Enteral nutrition
• Parenteral nutrition
• Special pharmaceuticals

Regional Outlook (Revenue in USD Million; 2016–2026)

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • France
  • UK
  • Spain
  • Italy
  • Rest of the Europe
• Asia Pacific
  • China
  • India
  • Japan
  • Rest of Asia-Pacific
• Middle East & Africa
• Latin America
  • Brazil

Request a customization of the report @ https://www.reportsanddata.com/request-customization-form/2250

Key Points Covered in the Report:

• Key insights into the latest growth trends, developments, technological and product advancements, and research and development scenario
• Analysis of micro- and macro-economic factors and regulatory framework
• In-depth evaluation of factors such as cost, capacity, rates of production and consumption, gross revenue, profit margin, demand and supply ratio, import/export, market share, market size, and market trends
• SWOT analysis, Porter’s Five Forces Analysis, investment return analysis, and feasibility analysis to offer a comprehensive view of the competitive landscape
• Strategic recommendations to established market players and new entrants to overcome limitations and entry-level barriers in the global market landscape
• Analysis of market drivers, restraints, challenges, limitations, threats, growth prospects and opportunities

Thank you for reading the report. The report can be customize as per requirements of the clients. For further information or query about customization, please reach out to us and we will offer you the report best suited for your needs.

Explore Reports and Data’s Prime Analysis of the global Healthcare & Pharmaceutical Industry:

Pet Care E-Commerce Market @ https://www.google.cm/url?q=https://www.reportsanddata.com/report-detail/pet-care-e-commerce-market

Hematology Analyzers and Reagents Market @ https://www.google.com.bz/url?q=https://www.reportsanddata.com/report-detail/hematology-analyzers-and-reagents-market

Spine Biologics Market @ https://www.google.com.jm/url?q=https://www.reportsanddata.com/report-detail/spine-biologics-market

Spine Therapy Market @ https://www.google.kg/url?q=https://www.reportsanddata.com/report-detail/spine-therapy-market

Diagnostic Reagent Market @ https://www.google.bj/url?q=https://www.reportsanddata.com/report-detail/diagnostic-reagent-market

About Reports and Data

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise.

Contact Us:

John W

Head of Business Development

Reports and Data | Web: www.reportsanddata.com

Direct Line: +1-212-710-1370

E-mail: sales@reportsanddata.com

Read Full Press Release: https://www.reportsanddata.com/press-release/global-home-infusion-therapy-market

The post Home Infusion Therapy Market Size To Reach USD 38.41 Billion By 2026 – Reports and Data first appeared on News Degree | Hub for Latest and Trending News from Around the Globe.

Ageing demographics, rapid technological developments, increasing adoption of home infusion therapies, favourable government policies and regulations are are key factors contributing to high CAGR of Home infusion therapy during forecast period.

According to current analysis of Reports and Data, the global Home Infusion Therapy Market was valued at USD 22.03 billion in 2018 and is expected to reach USD 38.41 billion by the year 2026, at a CAGR of 7.2%. Infusion therapy involves the administration of drugs intravenously. It is prescribed when a patient’s condition is much severe and cannot be treated effectively by oral medications. Receiving this therapy in homecare settings rather than hospitals is referred to as home infusion therapy. Home infusion therapies are very cost-effective, and technological advancements have facilitated safe and effective administration of infusion therapies at home. The advantage infusion offers is that it helps deliver a precise dose of the drug quickly and efficiently, and in a well-controlled manner throughout the body. It is also used for irritating solutions; those can cause pain and even damage tissues if administered by subcutaneous or intramuscular injection.

Moving care into the home is a very important step of change in healthcare. The approach is patient-centric. Home infusion therapy let patients reduce or even totally avoid outpatient hospital visits, and allows them to resume normal routines and work behaviors while still treating their illness. Home infusion therapy works closely with the patient to ensure that such services are appropriate and in the interest of the best patient care. Moreover, the outcome of home infusion therapy is reliable.  Favorable government policies and regulations, increasing geriatric population, rapid technological developments, and increasing adoption of home infusion therapies, are some of the key factors propelling market growth in the industry. High prevalence of chronic diseases such as HIV, cancer, diabetes is further expected to fuel market growth. Home infusion drugs are often not readily available through standard pharmacies and comparatively higher in cost. Most are obtained through hospital pharmacies, licensed home infusion agencies, or mail-order discount drug supply companies that can express deliver the drugs directly to the patient’s home. However, increasing risk with patient’s safety and occurrence of mistakes while using infusion devices and issues related to reimbursement policies for home infusion therapy are the major hindrance for market growth during the forecast period.

Get a sample of the report @ https://www.reportsanddata.com/sample-enquiry-form/2250  

Further key findings from the report suggest

• Home Infusion Therapy is growing at a CAGR of 3% in Asia Pacific followed by North America and Europe, with 7.2 % and 6.9% CAGR, respectively. High incidence of chronic diseases and availability of cost-effective home infusion therapies in developing and developed economies are expected to accelerate the market growth for home infusion therapy during forecast period across all regions
• As of 2018, Anti-infective application segment is expected to dominate Home infusion therapy which holds the market share of 33.9% of the global market. North America region is the chief revenue generating source for this product segment, followed by Europe and Asia-Pacific regions
• Chemotherapy is expected to be the fastest growing market segment during forecast period 2019-2026 with a CAGR of 7.7%. It is also the second largest segment in terms of revenue generation after anti-infective segment. For instance, according to the data of cancer organization, by January 1 2030, it is estimated that the population of cancer survivors will increase to more than 22.1 million due to the growth and aging of the population alone
• Infusion pumps segment led the global infusion therapy market with a market share of 34.7% in 2018 and is forecasted to continue its dominance during the forecast period. Extensive application in delivering fluids containing nutrients and medications in controlled dosages is anticipated to fuel market growth
• Needleless connectors segment is anticipated to witness lucrative growth with a CAGR of 7.9% registering fastest growth during the forecast period.
• Key players in the home infusion therapy industry are taking initiatives to educate and promote home infusion therapy among the patients by providing educational tools and apps that can be utilized for infusion therapies. For instance, in October 2018, Baxter International Inc. in collaboration with American Society for Parenteral and Enteral Nutrition (ASPEN) launched SmartPN tool to help reduce clinical malnutrition.
• Asia Pacific is expected to account for the 21.1% of the global Home Infusion Therapy. Developing nations such China, and India are likely to witness high growth
• North America region accounts for the largest market share of 37.6% followed by Europe
• Key participants include Baxter, B. Braun Melsungen AG, ICU Medical Inc., Fresenius Kabi AG, Terumo Corporation, JMS Co. Ltd., CareFusion Corporation, Smiths Medical and Caesarea Medical Electronics.

Request a discount on the report @ https://www.reportsanddata.com/discount-enquiry-form/2250

For the purpose of this report, Reports and Data has segmented the Home Infusion Therapy on the basis of product, application, and region:

Product (Revenue, USD Million; 2016–2026)

• Infusion pumps
• Intravenous sets
• IV Cannulas
• Needleless connectors

Application (Revenue, USD Million; 2016–2026)

• Anti- infective
• Endocrinology
• Hydration therapy
• Chemotherapy
• Enteral nutrition
• Parenteral nutrition
• Special pharmaceuticals

Regional Outlook (Revenue in USD Million; 2016–2026)

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • France
  • UK
  • Spain
  • Italy
  • Rest of the Europe
• Asia Pacific
  • China
  • India
  • Japan
  • Rest of Asia-Pacific
• Middle East & Africa
• Latin America
  • Brazil

Request a customization of the report @ https://www.reportsanddata.com/request-customization-form/2250

Key Points Covered in the Report:

• Key insights into the latest growth trends, developments, technological and product advancements, and research and development scenario
• Analysis of micro- and macro-economic factors and regulatory framework
• In-depth evaluation of factors such as cost, capacity, rates of production and consumption, gross revenue, profit margin, demand and supply ratio, import/export, market share, market size, and market trends
• SWOT analysis, Porter’s Five Forces Analysis, investment return analysis, and feasibility analysis to offer a comprehensive view of the competitive landscape
• Strategic recommendations to established market players and new entrants to overcome limitations and entry-level barriers in the global market landscape
• Analysis of market drivers, restraints, challenges, limitations, threats, growth prospects and opportunities

Thank you for reading the report. The report can be customize as per requirements of the clients. For further information or query about customization, please reach out to us and we will offer you the report best suited for your needs.

Explore Reports and Data’s Prime Analysis of the global Healthcare & Pharmaceutical Industry:

Pet Care E-Commerce Market @ https://www.google.cm/url?q=https://www.reportsanddata.com/report-detail/pet-care-e-commerce-market

Hematology Analyzers and Reagents Market @ https://www.google.com.bz/url?q=https://www.reportsanddata.com/report-detail/hematology-analyzers-and-reagents-market

Spine Biologics Market @ https://www.google.com.jm/url?q=https://www.reportsanddata.com/report-detail/spine-biologics-market

Spine Therapy Market @ https://www.google.kg/url?q=https://www.reportsanddata.com/report-detail/spine-therapy-market

Diagnostic Reagent Market @ https://www.google.bj/url?q=https://www.reportsanddata.com/report-detail/diagnostic-reagent-market

About Reports and Data

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise.

Contact Us:

John W

Head of Business Development

Reports and Data | Web: www.reportsanddata.com

Direct Line: +1-212-710-1370

E-mail: sales@reportsanddata.com

Read Full Press Release: https://www.reportsanddata.com/press-release/global-home-infusion-therapy-market

The post Home Infusion Therapy Market Size To Reach USD 38.41 Billion By 2026 – Reports and Data first appeared on News Degree | Hub for Latest and Trending News from Around the Globe.